These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1329 related items for PubMed ID: 24464774

  • 21. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W, West E, Santos M, Skali H, Groarke JD, Forman DE, Shah AM.
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [Abstract] [Full Text] [Related]

  • 22. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D, Simitsis P, Bistola V, Triposkiadis F, Ikonomidis I, Katsanos S, Bakosis G, Hatziagelaki E, Lekakis J, Mebazaa A, Parissis J.
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [Abstract] [Full Text] [Related]

  • 23. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study.
    Kasahara S, Sakata Y, Nochioka K, Yamauchi T, Onose T, Tsuji K, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Miyata S, Shimokawa H, CHART-2 Investigators.
    Heart Vessels; 2018 Sep; 33(9):997-1007. PubMed ID: 29569034
    [Abstract] [Full Text] [Related]

  • 24. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT, Rickenbacher P, Rickli H, Abbühl H, Gutmann M, Erne P, Vuilliomenet A, Peter M, Pfisterer M, Brunner-La Rocca HP, TIME-CHF Investigators.
    Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
    [Abstract] [Full Text] [Related]

  • 25. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y.
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [Abstract] [Full Text] [Related]

  • 26. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP, Gamble GD, Ling LH, Sim D, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Cameron VA, Poppe K, Lund M, Devlin G, Troughton R, Richards AM, Doughty RN.
    Eur Heart J; 2018 May 21; 39(20):1770-1780. PubMed ID: 29390051
    [Abstract] [Full Text] [Related]

  • 27. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K, Sakata Y, Nochioka K, Miura M, Yamauchi T, Onose T, Abe R, Oikawa T, Kasahara S, Sato M, Shiroto T, Takahashi J, Miyata S, Shimokawa H, CHART-2 Investigators.
    Eur J Heart Fail; 2017 Oct 21; 19(10):1258-1269. PubMed ID: 28370829
    [Abstract] [Full Text] [Related]

  • 28. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
    Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJ.
    Eur J Heart Fail; 2016 Dec 21; 18(12):1508-1517. PubMed ID: 27427441
    [Abstract] [Full Text] [Related]

  • 29. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction.
    Lok DJ, Klip IT, Voors AA, Lok SI, Bruggink-André de la Porte PW, Hillege HL, Jaarsma T, van Veldhuisen DJ, van der Meer P.
    Eur J Heart Fail; 2014 Sep 21; 16(9):958-66. PubMed ID: 25082741
    [Abstract] [Full Text] [Related]

  • 30. How do patients with heart failure with preserved ejection fraction die?
    Chan MM, Lam CS.
    Eur J Heart Fail; 2013 Jun 21; 15(6):604-13. PubMed ID: 23610137
    [Abstract] [Full Text] [Related]

  • 31. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S, Li X.
    High Blood Press Cardiovasc Prev; 2019 Oct 21; 26(5):405-411. PubMed ID: 31625118
    [Abstract] [Full Text] [Related]

  • 32. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A, Senni M, Barbati G, Greene SJ, Poli S, Zambon E, Di Nora C, Cioffi G, Tarantini L, Gavazzi A, Sinagra G, Di Lenarda A.
    Eur J Heart Fail; 2018 Sep 21; 20(9):1257-1266. PubMed ID: 29917301
    [Abstract] [Full Text] [Related]

  • 33. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH.
    Eur J Heart Fail; 2017 Dec 21; 19(12):1606-1614. PubMed ID: 28371075
    [Abstract] [Full Text] [Related]

  • 34. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V, Hwang SJ, Redfield MM, Zakeri R, Lin G, Borlaug BA.
    Circ Heart Fail; 2015 Mar 21; 8(2):295-303. PubMed ID: 25593126
    [Abstract] [Full Text] [Related]

  • 35. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension.
    Salamon JN, Kelesidis I, Msaouel P, Mazurek JA, Mannem S, Adzic A, Zolty R.
    J Card Fail; 2014 Jul 21; 20(7):467-75. PubMed ID: 24858070
    [Abstract] [Full Text] [Related]

  • 36. Prognostic Significance of Resting Heart Rate and Use of β-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure Registry.
    Li SJ, Sartipy U, Lund LH, Dahlström U, Adiels M, Petzold M, Fu M.
    Circ Heart Fail; 2015 Sep 21; 8(5):871-9. PubMed ID: 26243796
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients.
    Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi-Makaya M, Yamada S, Yokoshiki H, Tsutsui H, JCARE-CARD Investigators.
    Circ J; 2012 Sep 21; 76(7):1662-9. PubMed ID: 22481105
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 67.